You are here
- Home
- Therapy Areas
Gastrointestinal
The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- Expand All
- Collapse All
-
expand
AZD3355 Dose-escalation Study in Healthy Males
- Study Id
- D9120C00030
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Study Name
- D9120C00030
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Apr 2, 2009
- D9120C00030.pdf (505 KB)
-
expand
TLESR-impedance Study in Patients
- Study Id
- D9120C00020
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Study Name
- D9120C00020
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Dec 2, 2008
- D9120C00020.pdf (524 KB)
-
expand
Drug Interaction Study Between AZD3355 and Nexium
- Study Id
- D9120C00016
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Study Name
- D9120C00016
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Dec 4, 2008
- D9120C00016.pdf (529 KB)
-
expand
Symptom Improvements in GERD Patients
- Study Id
- D9120C00011
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Study Name
- D9120C00011
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Oct 24, 2007
- D9120C00011.pdf (160 KB)
-
expand
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (C27)
- Study Id
- D9120C00027
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Study Name
- D9120C00027
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jun 23, 2009
- D9120C00027.pdf (143 KB)
-
expand
Renal Impairment Study
- Study Id
- D9120C00022
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Study Name
- D9120C00022
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jul 20, 2010
- D9120C00022.pdf (608 KB)
-
expand
A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study.
- Study Id
- NIS-GBG-NEX-2009/1
- Disease
- acid reflux
- Drug Name
- Nexium
- Study Name
- NIS-GBG-NEX-2009/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 7, 2011
- NIS-GBG-NEX-2009_1.pdf (202 KB)
-
expand
Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
- Study Id
- NIS-GEU-DUM-2008/1
- Disease
- acid reflux
- Drug Name
- non drug study (gastrointestinal)
- Study Name
- NIS-GEU-DUM-2008/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Dec 2, 2010
- NIS-GEU-DUM-2008_1.pdf (374 KB)
-
expand
Omeprazole and Ranitidine in the Treatment of Patients with Erosive Esophagitis Not Responding to Treatment withH2-Receptor Antagonists: A Double-Blind, Controlled, Multicentre study.
- Study Id
- I-613
- Disease
- acid reflux
- Drug Name
- Losec
- Study Name
- I-613
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 1971
- I-613.pdf (85 KB)
-
expand
Omeprazole in the Long-Term Management of Duodenal Ulcers – A comparative study of omeprazole and ranitidine in high risk duodenal ulcer disease.
- Study Id
- I-598
- Disease
- acid reflux
- Drug Name
- Losec
- Study Name
- I-598
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jan 18, 1971
- I-598.pdf (70 KB)
- Expand All
- Collapse All
